Notice ID: e1ab2f523edc4f3eb47be6a075978711Combined Synopsis/SolicitationArchived
Vivo Efficacy of Blood stable Thiobenzamides
Archived on September 20, 2026. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 9:00 AM EDT
- Posted
- September 10, 2026
- Notice type
- Combined Synopsis/Solicitation
- Set-aside
- No Set aside used
- NAICS
- 325414: Biological Product (except Diagnostic) Manufacturing
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NATIONAL INSTITUTES OF HEALTH OLAO
- Place of performance
- Bethesda, Maryland, 20892
- Last updated
- Oct 28, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- 75N98026Q01123
- Notice ID
- e1ab2f523edc4f3eb47be6a075978711
Description
COMBINED SYNOPSIS / SOLICITATION
See attached
Solicitation No.: 75N98026Q01123
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Towanda Daniels
Documents
Files (1)
- Download
Solicitation 75N98026Q01123.pdf
188 KBAdded in Combined Synopsis/Solicitation version 3Posted
Lifecycle
- 1Version 1Combined Synopsis/SolicitationArchived
Vivo Efficacy of Blood stable Thiobenzamides
- 3Version 3Combined Synopsis/SolicitationArchivedCurrent
Vivo Efficacy of Blood stable Thiobenzamides
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75N98026Q01123
Archive Date
Sep 20, 2026
Office Address
BETHESDA, MD, 20892